Table 2.

NMR data (700 MHz ¹H, 175 MHz ¹³C, DMSO-d₆) for 3′-epiverrucarin X (3)

Position	δC, type	δH (mult., J)	NOESY	HMBC
2	78.1, CH	3.75, d (5.0)	13a
3α	34.5, CH2	2.43, d (8.1)	11	2, 5, 11
3β		1.98, dt (15.7, 4.8)
4	75.7, CH	5.79, dd (8.1, 3.8)	11, 15
5	48.9, C
6	43.6, C
7α	19.3, CH2	1.60, t (12.8)	3′	7
7β		1.70, t (15.7)	2′, 4′b
8α	22.1, CH2	1.80, m
8β		2.28, d (8.1)
9	137, C
10	131.0, CH	6.43, brs		16
11	65.1, CH	3.87, d (3.4)	3α, 4	5, 9, 10
12	65.2, C
13a	46.9, CH2	3.00, d (4.0)	2	12
13b		2.75, d (4.1)	14	12
14	7.0, CH3	0.71, s	13b	4, 5, 6, 11
15a	61.6, CH2	4.23, d (12.3)	4, 3′	5, 6, 11, 1′
15b		4.05, d (12.7)		5, 6, 7
16	168, C
1′	173.5, C
2′	72.7, CH	4.02, d (1.9)	7β, 4′b	1′, 3′, 4′, 12′
3′	32.3, CH	2.15, m	7α, 15a
4′a	31.9, CH2	1.76, t (15.7)
4′b		1.59, t (12.8)	7β, 2′
5′a	61.1, CH2	4.29, m
5′b		3.89, t (4.8)	12
6′	164.9, C
7′	127.3, CH	6.18, d (15.6)		6′, 9′
8′	138.5, CH	7.79, dd (15.6, 11.6)		6′, 10′
9′	138.1, CH	6.82, d (11.4)		7′, 11′
10′	126.3, CH	6.28, d (11.1)		8′, 11′
11′	165.6, C
12′	10.5, CH3	0.73, d (6.8)	5′b	2′, 3′, 4′